Loading the records…
Loading the records…
S5127 proposes to exclude clinical trial participant compensation from gross income, potentially lowering trial costs and improving enrollment. This is a modest positive for clinical research organizations like IQVIA and ICON, but the bill is in early stage with low near-term market impact.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
The bill is too early and small to have measurable market implications. No real market data is provided, but structurally, CROs are the most exposed. The bill does not change the competitive landscape or revenue outlook for the major CROs at this stage.
Senator Jim Banks (R-IN) introduced S5127 on July 23, 2026, which would amend the Internal Revenue Code to exclude from gross income compensation paid to clinical trial participants. The bill was read twice and referred to the Senate Committee on Finance. It has one original cosponsor, Senator Catherine Cortez Masto (D-NV), indicating some bipartisan support but no further legislative action. The bill is at an early stage.
The mechanism is a tax exclusion, not an appropriation. It does not allocate any federal funds. Instead, it reduces the tax liability for clinical trial participants, effectively lowering the after-tax cost of compensation for sponsors. This could make it cheaper for pharmaceutical and biotech companies to recruit and retain trial participants, potentially accelerating enrollment and reducing overall trial costs. However, the magnitude is small relative to total R&D budgets.
There is no convergence with other signals provided. The bill stands alone as a narrow tax provision.
Structural winners are contract research organizations (CROs) that manage clinical trials. IQVIA (IQV) and ICON (ICLR) are the largest pure-play CROs, and they would see modest tailwinds if the bill encourages sponsors to increase trial activity. Large pharmaceutical companies (e.g., Pfizer, Merck) also benefit but the impact is diluted across their massive revenue streams. The bill is too early to justify significant market moves.
Timeline: The bill must pass the Senate Finance Committee, then the full Senate, then the House, and be signed by the President. Given the 119th Congress has until January 2027, the bill's chances are uncertain. Investors should monitor committee markup and any companion bill in the House.
Matched on shared policy language across AI analyses, with ticker & timing weight
Clinical Trial Modernization Act
To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.
SEQIRUS INC: $42.8M Department of Health and Human Services Contract
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →